A coronavirus vaccine can’t come at the expense of fighting the virus now

Government investment in a cancer vaccine had drawbacks

Washington Post

by Prof. Robin Scheffler

The ink is still drying on a $1.95 billion deal between the United States and Pfizer to deliver 100 million doses of an experimental coronavirus vaccine to Americans as soon as this winter. The contract is the largest awarded by “Operation Warp Speed,” the Trump administration’s ambitious plan to accelerate the production of a vaccine, and arrives on the heels of billions of dollars channeled to other pharmaceutical firms.

READ MORE: A coronavirus vaccine can’t come at the expense of fighting the virus now